Gene TherapyReported
McKenzie Is Preparing to Become CHLA's First Casgevy Patient
A young actress and Spelman graduate is preparing for Casgevy after years of sickle-cell pain crises, but her treatment story is still pre-infusion.
Why now
McKenzie's story lets VV track a Casgevy journey from collection and manufacturing through infusion, rather than only covering the post-treatment headline.
- Overclaim risk
- medium-high
- Primary source
- Official
- Published
- Jun 27, 2026